Japan’s Daiichi Sankyo to add China, US production lines amid tariff risk

TOKYO — Japanese drugmaker Daiichi Sankyo will spend roughly 300 billion yen ($1.9 billion) to set up production facilities for a targeted cancer medicine in Japan, the U.S., Germany and China, …